Treatment of Plantar Warts

Plantar Wart Clinical Trial

Official title:

Comparative Study Between Topical30%Potassium Hydroxide Solution and Topical 45% Hydrogen Peroxide Solution in Treatment of Plantar Warts

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05198180
• Other study ID #: Sohag-Mes-21-11-07
• Status: Not yet recruiting
• Phase: Phase 3
• Start date: February 2022
• Est. completion date: December 2022

Study information

• Verified date: January 2022
• Source: Sohag University
• Contact: Samar Sa Ahmed, Resident
• Phone: 01152471005
• Email: Summersayed156[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is to compare the efficacy and safety of topical 30% potassium hydroxide solution and topical 45% hydrogen peroxide solution in treatment of plantar warts.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: December 2022
• Est. primary completion date: June 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years and older

Eligibility

Inclusion Criteria:

• confirmed diagnosis by clinical and dermoscopic examination of plantar warts

Exclusion Criteria:

• history of hypersensitivity to any component used in this study
• pregnancy and breastfeeding
• patients who receive immune suppressive therapy
• patients who received any wart treatments during the last 2 months before enrollent in the study
• patients who refused participation in the study

Related Conditions & MeSH terms

• Foot Diseases
• Plantar Wart
• Warts

Intervention

Drug:
• Topical 30%Potassium hydroxide solution
Patients will apply the solution every day under occlusion for 3 months
• Topical 45% hydrogen peroxide solution
Patients will apply the solution every day under occlusion

Locations

Country	Name	City	State
Egypt	Sohag faculty of medicine	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in the size of the plantar warts	Decrease in the size of warts measured by a ruler	12 weeks after end of treatment